Muscarinic receptor subtypes and management of the overactive bladder (Q35031220)

5 August 2017

1 reference

title

Muscarinic receptor subtypes and management of the overactive bladder (English)

1 reference

5 August 2017

author

Christopher R Chapple

object named as

Christopher R Chapple

series ordinal

1

0 references

author name string

Tomonori Yamanishi

series ordinal

2

1 reference

5 August 2017

Russell Chess-Williams

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

60

1 reference

5 August 2017

issue

5 Suppl 1

1 reference

5 August 2017

page(s)

82-8; discussion 88-9

1 reference

Atropine Resistance of Transmurally Stimulated Isolated Human Bladder Muscle

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

The pharmacological treatment of urinary incontinence.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

The role of M(2)-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Characterization of the functional muscarinic receptors in the rat urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Pharmacological characterization of muscarinic receptors in rabbit isolated iris sphincter muscle and urinary bladder smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Evidence for the presence of regional differences in the subtype specificity of muscarinic receptors in rabbit lower urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

M3 muscarinic receptors but not M2 mediate contraction of the porcine detrusor muscle in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Evaluation of mRNAs encoding muscarinic receptor subtypes in human detrusor muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Muscarinic Receptor Stimulation of Phosphoinositide Hydrolysis in the Human Isolated Urinary Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Tolterodine--a new bladder-selective antimuscarinic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Muscarinic receptors--characterization, coupling and function

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Muscarinic acetylcholine receptor subtypes in smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Characterization of the interaction between muscarinic M2 receptors and beta-adrenoceptor subtypes in guinea-pig isolated ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

M2 receptors in genito-urinary smooth muscle pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Function of M3 muscarinic receptors in the rat urinary bladder following partial outlet obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Evidence for inhibitory nicotinic and facilitatory muscarinic receptors in cholinergic nerve terminals of the rat urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

M1 muscarinic receptor-mediated facilitation of acetylcholine release in the rat urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Function, signal transduction mechanisms and plasticity of presynaptic muscarinic receptors in the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Prejunctional muscarinic receptors modulating acetylcholine release in rabbit detrusor smooth muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Low-dose oxybutynin for the treatment of urge incontinence: good efficacy and few side effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Oxybutynin for detrusor instability with adjuvant salivary stimulant pastilles to improve compliance: results of a multicentre, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

A randomized controlled trial comparing the efficacy of controlled-release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Absorption of oxybutynin from vaginal inserts: drug blood levels and the response of the rabbit bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Treatment of detrusor instability with oxybutynin rectal suppositories

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Inhibitory effects of propiverine on rat and guinea-pig urinary bladder muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Dose-ranging study of tolterodine in patients with detrusor hyperreflexia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Cost-effectiveness of new treatments for overactive bladder: the example of tolterodine, a new muscarinic agent: a Markov model

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Muscarinic antagonists in development for disorders of smooth muscle function

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

An Objective Comparison of the Effects of Parenterally Administered Drugs in Patients Suffering from Detrusor Instability

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

Efficacy and cardiac safety of propiverine in elderly patients - a double-blind, placebo-controlled clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901803-4

7 January 2021

10.1016/S0090-4295(02)01803-4

Identifiers

DOI

1 reference

5 August 2017

1 reference